Branded

BRIDGEWATER, N.J. Sanofi-Aventis has tapped actors Paul and Mira Sorvino to launch an awareness program aimed to help people living with diabetes and those who support them.

The "Diabetes Co-Stars" program provides family and friends of diabetics with advice on lifestyle choices, healthy cooking, promoting physical activity and treatment options including insulin, Sanofi-Aventis said. DiabetesCoStars.com provides links to the Sanofi-Aventis diabetes social media pages, including Facebook and Twitter.

GLASGOW, Ky. Amneal Pharmaceuticals will have a grand opening of its newly expanded distribution and sales center next week, the generic drug maker said Monday.

Amneal announced the grand opening of the center in Glasgow, Ky., set to take place Monday. Representatives from the municipal and state governments, the Tennessee Valley Authority, state legislators and possibly members of Congress are expected to attend.

RIDGEFIELD, Conn. A Food and Drug Administration advisory committee has recommended approval of a drug for patients with atrial fibrillation.

The FDA cardiovascular and renal drugs advisory committee voted unanimously to recommend approval for Boehringer Ingelheim's Pradaxa (dabigatran etexilate), for preventing strokes in atrial fibrillation patients. For the last 50 years, warfarin has been the only oral anticoagulant drug available for this purpose.

WOODCLIFF LAKE, N.J. The Food and Drug Administration has accepted for review a regulatory approval application for a patch made by Eisai to treat Alzheimer’s disease, the drug maker said Friday.

The agency will review a patch formulation of Aricept (donepezil hydrochloride), a weekly patch for treating mild, moderate and severe stages of the disease. The drug already is available in tablet form.

FAIRFIELD, N.J. The Healthcare Businesswomen’s Association has given the U.S. subsidiary of French drug maker Sanofi-Aventis its 2010 HBA ACE Award for building women’s leadership in the company, the HBA said Thursday.

PRINCETON, N.J. Working Mother magazine has named drug maker Novo Nordisk one of the best companies in the country for family-friendly benefits, the company said Thursday.

The U.S. subsidiary of the Danish drug maker was named a Working Mother 100 Best Company for programs designed to help families balance work-life needs, such as adoption reimbursement, health benefits, paid time off and assistance for families sending their kids to college.

SILVER SPRING, Md. Drug maker Forest Pharmaceuticals will pay more than $300 million to the federal government as part of a plea agreement over alleged improper drug distribution and obstructing a Food and Drug Administration inspection.

WASHINGTON The Food and Drug Administration has approved a new treatment for gout, a painful condition that affects 3 million adults in the United States.

The FDA announced the approval of Savient Pharmaceuticals’ Krystexxa (pegloticase), a biotech drug for people who have not responded to or tolerated conventional therapies.